Pharmafile Logo

ASH 2020

- PMLiVE

ASH 2020: Gilead eyes new Yescarta indication, Vertex/CRISPR make headway in sickle cell and more

A round-up of some of the key data from the annual American Society of Hematology (ASH) meeting

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links